Colony Group’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-9,098
Closed -$246K 848
2021
Q2
$246K Sell
9,098
-340
-4% -$9.51K ﹤0.01% 695
2021
Q1
$283K Hold
9,438
0.01% 654
2020
Q4
$271K Hold
9,438
0.01% 640
2020
Q3
$230K Buy
+9,438
New +$204K 0.01% 655
2019
Q4
Sell
-12,884
Closed -$153K 770
2019
Q3
$153K Buy
12,884
+69
+0.5% +$1.28K ﹤0.01% 681
2019
Q2
$313K Buy
+12,815
New +$369K 0.01% 591

Other funds holding CVET

Colony Group's CVET Position: Q3 2021 in Review

Colony Group sold out of Covetrus, Inc. Common Stock (CVET) in Q3 2021, closing a stake of 9,098 shares — an estimated $246K sold.

Colony Group first reported a position in CVET in Q2 2019 and held it in 6 quarters. The position peaked at $313K in Q2 2019. 260 funds tracked by Wall St. Rank hold CVET as of Q3 2021.

  • Colony Group reported no remaining Covetrus, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Colony Group sold 9,098 Covetrus, Inc. Common Stock shares in Q3 2021, an estimated $246K.
  • Colony Group first reported a position in Covetrus, Inc. Common Stock in Q2 2019 and held it in 6 quarters.
  • Colony Group's Covetrus, Inc. Common Stock position peaked at $313K in Q2 2019.
  • 260 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q3 2021.

Based on Colony Group's 13F filing for Q3 2021, filed 17 Nov 2021.